P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients

4 Citations (Scopus)
53 Downloads (Pure)

Fingerprint

Dive into the research topics of 'P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences